Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas.

Autor: Hosoya E; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Ando J; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Division of Cell Therapy and Blood Transfusion Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Kinoshita S; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Furukawa Y; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Toyoshima Y; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Division of Cell Therapy and Blood Transfusion Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Azusawa Y; Division of Cell Therapy and Blood Transfusion Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Mitsumori T; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba 279-0021., Sato E; Deparatment of Hematology, Juntendo University Nerima Hospital, 3-1-19 Takanodai, Nerima-ku, Tokyo 177-8521., Takano H; Department of Hematology, Juntendo University Shizuoka Hospital, 1129 Nagaoka, Izunokuni-shi, Shizuoka 410-2295., Tsukune Y; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Watanabe N; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Takaku T; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Yasuda H; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Hamano Y; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Sasaki M; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Nojiri S; Medical Technology Innovation Center, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Ishii M; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421., Ando M; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421. m-ando@juntendo.ac.jp.

Publikováno v: Haematologica [Haematologica] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification".

Autor: Nitta H; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan., Takizawa H; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan., Mitsumori T; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan., Iizuka-Honma H; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan., Ochiai T; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.; Division of Hematology, Juntendo University Juntendo Hospital, Tokyo 113-0033, Japan., Furuya C; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.; Division of Hematology, Juntendo University Juntendo Hospital, Tokyo 113-0033, Japan., Araki Y; Department of Pathology and Microbiology, Division of Microbiology, Nippon University School of Medicine, Tokyo 113-8602, Japan., Fujishiro M; Institute for Environmental and Gender-Specific Medicine, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan., Tomita S; Department of Diagnostic Pathology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan., Hashizume A; Department of Diagnostic Pathology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan., Sawada T; Department of Clinical Laboratory, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan., Miyake K; Department of Clinical Laboratory, Faculty of Medical Sciences, Juntendo University, Tokyo 113-8421, Japan., Okubo M; Laboratory of Blood Transfusion, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan., Sekiguchi Y; Hematology Clinic, Saitama Cancer Center, Saitama 362-0806, Japan., Ando M; Division of Hematology, Juntendo University Juntendo Hospital, Tokyo 113-0033, Japan., Noguchi M; Department of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Jun 30; Vol. 13 (13). Date of Electronic Publication: 2024 Jun 30.

Properties of nuclear matter in cut-off field theory and renormalization group methods

Autor: Kouno, H., Mitsumori, T., Iwasaki, Y., Sakamoto, K., Noda, N., Koide, K., Hasegawa, A., Nakano, M.

The properties of nuclear matter are studied in the cut-off field theory. It is found that, under the Hartree approximation, the small cut-off makes the equations of state hard, especially at higher densities. The theory is modified in the framework

Externí odkaz: http://arxiv.org/abs/nucl-th/9605038

Compressional properties of nuclear matter in the relativistic mean field theory with the excluded volume effects

Autor: Kouno, H., Koide, K., Mitsumori, T., Noda, N., Hasegawa, A., Nakano, M.

Compressional properties of nuclear matter are studied by using the mean field theory with the excluded volume effects of the nucleons. It is found that the excluded volume effects make it possible to fit the empirical data of the Coulomb coefficient

Externí odkaz: http://arxiv.org/abs/nucl-th/9507016

Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.

Autor: Tsuchiya S; Department of Hematology, Juntendo University School of Medicine, Japan., Takaku T; Department of Hematology, Juntendo University School of Medicine, Japan., Watanabe N; Department of Hematology, Juntendo University School of Medicine, Japan., Iriyama N; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan., Kimura Y; Department of Hematology, Japan Community Health Care Organization Saitama Medical Center, Japan., Iwanaga E; Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Japan., Sugimoto KJ; Department of Hematology, Juntendo University Urayasu Hospital, Japan., Mitsumori T; Department of Hematology, Juntendo University Urayasu Hospital, Japan., Ishikawa M; Department of Hemato-oncology, Saitama Medical University International Medical Center, Japan., Nakazato T; Department of Hematology, Yokohama Municipal Citizen's Hospital, Japan., Fujita H; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Japan., Sato E; Department of Hematology, Juntendo University Nerima Hospital, Japan., Hatta Y; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan., Asou N; Department of Hemato-oncology, Saitama Medical University International Medical Center, Japan., Kizaki M; Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan., Tokuhira M; Department of Hematology, Japan Community Health Care Organization Saitama Medical Center, Japan., Ando M; Department of Hematology, Juntendo University School of Medicine, Japan., Kawaguchi T; Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Japan.; Department of Medical Technology, Kumamoto Health Science University, Japan.

Publikováno v: Internal medicine (Tokyo, Japan) [Intern Med] 2023 Nov 15; Vol. 62 (22), pp. 3299-3303. Date of Electronic Publication: 2023 Mar 31.